USPTO serial 75141610
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Cambridge, CB4 4WE, GB
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Paul F. Kilmer
PAUL F KILMER GADSBY & HANNAH LLPSTE 8001747 PENNSYLVANIA AVE N WWASHINGTON, DC 20006| Class | Description | Status | First use |
|---|---|---|---|
| 001 | chemical intermediate products; catalysts; synthons; chiral compounds all for use in the manufacture of scientific and pharmaceutical products | ABANDONED | — |
| 005 | pharmaceutical intermediate products; pharmaceutical, veterinary and sanitary substances | ABANDONED | — |
| 040 | manufacture of general product lines in the field of pharmaceuticals, chemical intermediates and pharmaceutical intermediates, to the order and specification of others; consultancy and advisory services relating thereto | ABANDONED | — |
| 042 | pharmaceutical and chemical research, development and manufacturing services; consultancy and advisory services relating thereto | ABANDONED | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 25, 1997 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| Apr 9, 1997 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jan 28, 1997 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 17, 1997 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 7, 1997 | DOCK | ASSIGNED TO EXAMINER | — |